Egg shell derived Nano-hydroxyapatite as a regenerative material in Direct Sinus Augmentation.

Phase 2

• Conditions: Health Condition 1: K068- Other specified disorders of gingiva and edentulous alveolar ridge

• Registration Number: CTRI/2024/07/070712
• Lead Sponsor: DrVikrant Dilip Sane

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 22 July 2024

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

1. Partially or completely edentulous posterior maxilla with residual height less than equal to 5mm.

2. 6 months gap between tooth extraction and implant placement.

3. Presence of healthy or restored adjacent teeth.

4. Patients with ASA category I or II.

5. Excellent oral hygiene.

Exclusion Criteria

1. Uncontrolled metabolic diseases, compromised immune system, haematological disorders, pregnancy, prior radiotherapy of maxillofacial region, chemotherapy, bone disease, medication or any other systemic illness which may affect prognosis of the treatment.

2. Radiographic evidence of maxillary sinus pathology.

3. History of sinusitis or maxillary sinus surgery.

4. Inadequate mouth opening.

5. Patients with habits of smoking, tobacco chewing, alcoholism, etc.

6. Patients not willing for egg shell derived graft material.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
CBCT scan will be used to determine density of bone and level of alveolar bone height, histomorphometric analysis will be used to evaluate presence of residual graft material and replacement of grafted material by host bone alongwith any resorptive or inflammatory changes.Timepoint: 180 days

Secondary Outcome Measures

Name	Time	Method
OPG will be taken to assess the stage of bone formation & clinical examination will be done to assess soft tissue healingTimepoint: 90 days